NCT00446485View on ClinicalTrials.gov

Efficacy and Safety of Ginkgo Biloba Extract in Mild Cognitive Impairment and Cerebrovascular Insufficiency

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Mild Cognitive ImpairmentCerebrovascular Insufficiency
Interventions
DRUG

Ginkgo biloba standardized extract 24/6

tablets, 120 mg/day (60 mg two times daily) during 6 months

DRUG

Ginkgo Biloba standardized extract 24/6

tablets, 60 mg/day during 6 months

DRUG

placebo

placebo during 6 months

Trial Locations (1)

10000

University Department of Neurology, Sestre milosrdnice University Hospital, Vinogradska 29, Zagreb

All Listed Sponsors
lead

Milsing d.o.o.

OTHER

NCT00446485 - Efficacy and Safety of Ginkgo Biloba Extract in Mild Cognitive Impairment and Cerebrovascular Insufficiency | Biotech Hunter | Biotech Hunter